|
Resolution: standard / high Figure 3.
Percentage of patients with putative protective antibody levels (≥1 mg/L) for serotype
23 F 6B and both 23 F and 6 B (C) at vaccination, at 4 to 6 weeks after vaccination,
and at 1.5-year follow-up in patients with rheumatoid arthritis (RA) and spondyloarthropathy
(SpA) treated with different antiinflammatory drugs.
Crnkic Kapetanovic et al. Arthritis Research & Therapy 2013 15:R1 doi:10.1186/ar4127 |
